Clinical Evaluation of a Daily Wear Frequent Replacement Silicone Hydrogel Lens
NCT ID: NCT03920280
Last Updated: 2022-07-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2019-05-22
2019-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of a Daily Wear Monthly Replacement Silicone Hydrogel Lens
NCT04178720
Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens
NCT04207749
Clinical Evaluation of a Silicone Hydrogel Daily Wear Monthly Replacement Contact Lens
NCT04422990
Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens
NCT04085328
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
NCT03586167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LID015385
LID015385 contact lenses worn in both eyes during waking hours only for at least 8 hours per day and 5 days per week over a 3-month exposure period. Lenses will be removed nightly for cleaning with CLEAR CARE.
LID015385 contact lenses
Investigational silicone hydrogel contact lenses
CLEAR CARE
Hydrogen peroxide-based cleaning and disinfecting system
Biofinity
Comfilcon A contact lenses worn in both eyes during waking hours only for at least 8 hours per day and 5 days per week over a 3-month exposure period. Lenses will be removed nightly for cleaning with CLEAR CARE.
Comfilcon A soft contact lenses
Commercially available silicone hydrogel contact lenses
CLEAR CARE
Hydrogen peroxide-based cleaning and disinfecting system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LID015385 contact lenses
Investigational silicone hydrogel contact lenses
Comfilcon A soft contact lenses
Commercially available silicone hydrogel contact lenses
CLEAR CARE
Hydrogen peroxide-based cleaning and disinfecting system
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Manifest cylinder ≤ 0.75 diopter (D) in each eye.
Exclusion Criteria
* Monovision contact lens wearers.
* Habitually wearing Biofinity® lenses.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CDMA Project Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigator 6565
Maitland, Florida, United States
Alcon Investigator 6355
Orlando, Florida, United States
Alcon Investigator 6291
Pensacola, Florida, United States
Alcon Investigator 3950
Bloomington, Illinois, United States
Alcon Investigator 6567
Pittsburg, Kansas, United States
Alcon Investigator 6313
Powell, Ohio, United States
Alcon Investigator 6401
Warwick, Rhode Island, United States
Alcon Investigator 6353
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLL949-C009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.